Primecap Management Co. CA trimmed its stake in Nektar Therapeutics (NASDAQ:NKTR – Free Report) by 11.7% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 7,197,983 shares of the biopharmaceutical company’s stock after selling 951,893 shares during the period. Primecap Management […]